SUMMARYBehçetÕs disease, a systemic vasculitis, can cause varying degrees of activity limitation, fatigue and quality of life impairment. To date, there have been no studies regarding sleep disturbance and its relationship with fatigue and life quality in BehçetÕs disease. We aimed to evaluate sleep disorders and polysomnographic parameters, and to determine their relationship with fatigue and quality of life in BehçetÕs disease. Fiftyone patients with BehçetÕs disease without any neurological involvement were interviewed regarding sleep disorders. Twenty-one subjects with no sleep complaints were included as the control group. Sleep-related complaints were evaluated in a face-to-face interview. Sleep quality, excessive daytime sleepiness, fatigue, depression, anxiety, disease activity ⁄ severity, and quality of life questionnaires and an overnight polysomnography were performed. Prevalences of restless legs syndrome (35.3%) and obstructive sleep apnea syndrome with ⁄ without other sleep disorders (32.5%) were higher than in the control group and the general population. Fatigue was higher in patients with restless legs syndrome and obstructive sleep apnea syndrome, and in those with lower minimum oxygen saturation; hence, only patients with restless legs syndrome had quality of life impairment. Sleep efficiency index and sleep continuity index were lower, and wake after sleep onset, respiratory disturbance index and apnea-hypopnea index were higher than in controls (P < 0.01). Neither sleep disorders nor polysomnographic parameters were related to disease activity and severity. In conclusion, it is important to question sleep disorder followed by a polysomnography, if necessary, in order to improve quality of life and fatigue in BehçetÕs disease.
INTRODUC TIONBehçetÕs disease (BD) was first described by Turkish dermatologist Hulusi Behçet in 1937 as a triad of recurrent oral aphthae, genital ulcerations and relapsing uveitis (Behçet, 1937). BD is a chronic, systemic vasculitis with an unknown etiology, which can affect blood vessels (mainly veins) of all sizes. The clinical picture of BD is widely variable. In addition to the mucocutaneous lesions, ocular, vascular, articular, gastrointestinal, urogenital, pulmonary and neurological involvements have been seen during its course, and are characterized by a heterogeneous severity. BD progresses with unpredictable flares alternating with remission periods (Harzallah et al., 2008).The complexity of signs and symptoms in BD can disturb an individualÕs lifestyle by causing limitation in activity. As a result, numerous psychological problems may arise. Furthermore, it was shown in some studies that in patients with BD with fatigue, there was a significant association with impaired quality of life (QoL;Bodur et al., 2006). It was reported that